Envista (NYSE:NVST) Posts Earnings Results, Beats Estimates By $0.06 EPS

Envista (NYSE:NVSTGet Free Report) announced its earnings results on Thursday. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.06, FiscalAI reports. Envista had a return on equity of 5.90% and a net margin of 0.58%. Envista updated its FY 2026 guidance to 1.350-1.450 EPS.

Envista Price Performance

NYSE NVST traded up $1.15 during trading on Thursday, reaching $24.81. 9,440,264 shares of the company traded hands, compared to its average volume of 2,937,165. Envista has a 1-year low of $14.22 and a 1-year high of $25.41. The company has a market cap of $4.08 billion, a price-to-earnings ratio of 275.66, a P/E/G ratio of 1.02 and a beta of 1.01. The stock’s 50 day moving average price is $22.56 and its two-hundred day moving average price is $21.14. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.02 and a current ratio of 2.37.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Envista by 35.3% in the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,041 shares of the company’s stock valued at $62,000 after purchasing an additional 793 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after purchasing an additional 1,504 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in Envista by 378.0% in the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock valued at $47,000 after buying an additional 1,909 shares in the last quarter. Mariner LLC grew its stake in Envista by 19.7% during the third quarter. Mariner LLC now owns 13,761 shares of the company’s stock worth $280,000 after buying an additional 2,264 shares during the last quarter. Finally, Vise Technologies Inc. increased its holdings in shares of Envista by 9.5% during the third quarter. Vise Technologies Inc. now owns 30,418 shares of the company’s stock worth $620,000 after buying an additional 2,649 shares in the last quarter.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on NVST shares. Mizuho set a $24.00 price objective on Envista and gave the company a “neutral” rating in a research report on Tuesday, January 20th. Piper Sandler raised their price target on shares of Envista from $19.00 to $21.00 and gave the stock a “neutral” rating in a research report on Friday, January 30th. Robert W. Baird set a $27.00 price objective on shares of Envista in a research report on Friday, October 31st. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a research report on Monday, January 26th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Envista in a research note on Monday, December 29th. Five analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Envista presently has an average rating of “Hold” and an average price target of $22.75.

Get Our Latest Research Report on Envista

Envista Company Profile

(Get Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

Featured Articles

Earnings History for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.